These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11177669)

  • 1. Are all beta-blockers the same for chronic heart failure?
    Gottlieb SS
    Curr Cardiol Rep; 2001 Mar; 3(2):124-9. PubMed ID: 11177669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockade in heart failure: selective versus nonselective agents.
    Metra M; Nodari S; Dei Cas L
    Am J Cardiovasc Drugs; 2001; 1(1):3-14. PubMed ID: 14728047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol versus other beta-blockers in heart failure.
    Doggrell SA
    Expert Opin Investig Drugs; 2001 May; 10(5):971-80. PubMed ID: 11322870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers in heart failure: are pharmacological differences clinically important?
    Metra M; Cas LD; di Lenarda A; Poole-Wilson P
    Heart Fail Rev; 2004 Apr; 9(2):123-30. PubMed ID: 15516860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective or nonselective beta-adrenergic blockade in patients with congestive heart failure.
    Metra M; Nodari S; Boldi E; Dei Cas L
    Curr Cardiol Rep; 2000 May; 2(3):252-7. PubMed ID: 10980900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker treatment in heart failure.
    Bouzamondo A; Hulot JS; Sanchez P; Cucherat M; Lechat P
    Fundam Clin Pharmacol; 2001 Apr; 15(2):95-109. PubMed ID: 11468019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers for chronic heart failure: surviving longer but feeling better?
    Bolger AP; Al-Nasser F
    Int J Cardiol; 2003 Nov; 92(1):1-8. PubMed ID: 14602210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker benefit according to severity of heart failure.
    Bouzamondo A; Hulot JS; Sanchez P; Lechat P
    Eur J Heart Fail; 2003 Jun; 5(3):281-9. PubMed ID: 12798825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New and old beta-blockers in the treatment of heart failure].
    Metra M; Nodari S; Bignotti T; Gnesin P; Trussardi E; Cas LD
    Recenti Prog Med; 2002 Feb; 93(2):113-24. PubMed ID: 11887345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol in the treatment of chronic heart failure.
    Moe G
    Expert Opin Pharmacother; 2001 May; 2(5):831-43. PubMed ID: 11336626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta-adrenolytics in heart failure--are they all really equal?].
    Filipiak KJ; Opolski G
    Przegl Lek; 2005; 62 Suppl 2():39-42. PubMed ID: 16623117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
    Bauman JL; Talbert RL
    J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-adrenergic blockade on survival of patients with chronic heart failure.
    Packer M
    Am J Cardiol; 1997 Dec; 80(11A):46L-54L. PubMed ID: 9412542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.